# Federated Hermes, Inc.: financial statements, quarterly

FHI · NYSE · CIK 1056288 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fhi.md) · [Financials](/companies/fhi/financials.md) · [Filings](/companies/fhi/filings.md) · [Insiders](/companies/fhi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fhi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [403](/filings/0001056288-24-000025.md) | [391 d](/filings/0001056288-26-000007.md) | [396](/filings/0001056288-25-000016.md) | [403](/filings/0001056288-25-000021.md) | [408](/filings/0001056288-25-000030.md) | [425 d](/filings/0001056288-26-000007.md) | [424](/filings/0001056288-26-000018.md) | [425](/filings/0001056288-26-000026.md) | [469](/filings/0001056288-25-000030.md) | [483 d](/filings/0001056288-26-000007.md) | [479](/filings/0001056288-26-000018.md) | [503](/filings/0001056288-26-000026.md) |
| Operating income | $m | [101](/filings/0001056288-24-000025.md) | [103 d](/filings/0001056288-26-000007.md) | [98.6](/filings/0001056288-25-000016.md) | [40.7](/filings/0001056288-25-000021.md) | [112](/filings/0001056288-25-000030.md) | [110 d](/filings/0001056288-26-000007.md) | [132](/filings/0001056288-26-000018.md) | [117](/filings/0001056288-26-000026.md) | [129](/filings/0001056288-25-000030.md) | [136 d](/filings/0001056288-26-000007.md) | [126](/filings/0001056288-26-000018.md) | [133](/filings/0001056288-26-000026.md) |
| Income tax | $m | [26.7](/filings/0001056288-24-000025.md) | [31.3 d](/filings/0001056288-26-000007.md) | [29.0](/filings/0001056288-25-000016.md) | [23.4](/filings/0001056288-25-000021.md) | [32.3](/filings/0001056288-25-000030.md) | [28.5 d](/filings/0001056288-26-000007.md) | [32.2](/filings/0001056288-26-000018.md) | [34.1](/filings/0001056288-26-000026.md) | [34.2](/filings/0001056288-25-000030.md) | [32.9 d](/filings/0001056288-26-000007.md) | [33.8](/filings/0001056288-26-000018.md) | [37.2](/filings/0001056288-26-000026.md) |
| Net income | $m | [75.0](/filings/0001056288-24-000025.md) | [82.2 d](/filings/0001056288-26-000007.md) | [75.0](/filings/0001056288-25-000016.md) | [21.0](/filings/0001056288-25-000021.md) | [87.5](/filings/0001056288-25-000030.md) | [84.7 d](/filings/0001056288-26-000007.md) | [101](/filings/0001056288-26-000018.md) | [91.0](/filings/0001056288-26-000026.md) | [104](/filings/0001056288-25-000030.md) | [107 d](/filings/0001056288-26-000007.md) | [96.4](/filings/0001056288-26-000018.md) | [104](/filings/0001056288-26-000026.md) |
| Diluted EPS | $ per share | [0.86](/filings/0001056288-24-000025.md) | not reported | [0.89](/filings/0001056288-25-000016.md) | [0.20](/filings/0001056288-25-000021.md) | [1.06](/filings/0001056288-25-000030.md) | not reported | [1.25](/filings/0001056288-26-000018.md) | [1.16](/filings/0001056288-26-000026.md) | [1.34](/filings/0001056288-25-000030.md) | not reported | [1.27](/filings/0001056288-26-000018.md) | [1.38](/filings/0001056288-26-000026.md) |
| Basic EPS | $ per share | [0.86](/filings/0001056288-24-000025.md) | not reported | [0.89](/filings/0001056288-25-000016.md) | [0.20](/filings/0001056288-25-000021.md) | [1.06](/filings/0001056288-25-000030.md) | not reported | [1.25](/filings/0001056288-26-000018.md) | [1.16](/filings/0001056288-26-000026.md) | [1.34](/filings/0001056288-25-000030.md) | not reported | [1.27](/filings/0001056288-26-000018.md) | [1.38](/filings/0001056288-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [377](/filings/0001056288-24-000025.md) | [383](/filings/0001056288-26-000007.md) | [360](/filings/0001056288-25-000016.md) | [307](/filings/0001056288-25-000021.md) | [375](/filings/0001056288-25-000030.md) | [504](/filings/0001056288-26-000007.md) | [388](/filings/0001056288-26-000018.md) | [371](/filings/0001056288-26-000026.md) | [506](/filings/0001056288-25-000030.md) | [583](/filings/0001056288-26-000026.md) | [514](/filings/0001056288-26-000018.md) | [302](/filings/0001056288-26-000026.md) |
| Current assets | $m | [712](/filings/0001056288-23-000029.md) | [721](/filings/0001056288-25-000004.md) | [720](/filings/0001056288-24-000014.md) | [613](/filings/0001056288-24-000018.md) | [723](/filings/0001056288-24-000025.md) | [781](/filings/0001056288-26-000007.md) | [679](/filings/0001056288-25-000016.md) | [761](/filings/0001056288-25-000021.md) | [802](/filings/0001056288-25-000030.md) | [864](/filings/0001056288-26-000026.md) | [789](/filings/0001056288-26-000018.md) | [661](/filings/0001056288-26-000026.md) |
| Total assets | $m | [2,080](/filings/0001056288-23-000029.md) | [2,102](/filings/0001056288-25-000004.md) | [2,087](/filings/0001056288-24-000014.md) | [1,912](/filings/0001056288-24-000018.md) | [2,038](/filings/0001056288-24-000025.md) | [2,085](/filings/0001056288-26-000007.md) | [2,002](/filings/0001056288-25-000016.md) | [2,152](/filings/0001056288-25-000021.md) | [2,182](/filings/0001056288-25-000030.md) | [2,229](/filings/0001056288-26-000026.md) | [2,144](/filings/0001056288-26-000018.md) | [2,330](/filings/0001056288-26-000026.md) |
| Current liabilities | $m | [256](/filings/0001056288-23-000029.md) | [287](/filings/0001056288-25-000004.md) | [212](/filings/0001056288-24-000014.md) | [223](/filings/0001056288-24-000018.md) | [263](/filings/0001056288-24-000025.md) | [289](/filings/0001056288-26-000007.md) | [223](/filings/0001056288-25-000016.md) | [226](/filings/0001056288-25-000021.md) | [256](/filings/0001056288-25-000030.md) | [314](/filings/0001056288-26-000026.md) | [241](/filings/0001056288-26-000018.md) | [255](/filings/0001056288-26-000026.md) |
| Total liabilities | $m | [910](/filings/0001056288-23-000029.md) | [948](/filings/0001056288-25-000004.md) | [866](/filings/0001056288-24-000014.md) | [864](/filings/0001056288-24-000018.md) | [901](/filings/0001056288-24-000025.md) | [934](/filings/0001056288-26-000007.md) | [859](/filings/0001056288-25-000016.md) | [874](/filings/0001056288-25-000021.md) | [931](/filings/0001056288-25-000030.md) | [966](/filings/0001056288-26-000026.md) | [881](/filings/0001056288-26-000018.md) | [933](/filings/0001056288-26-000026.md) |
| Long-term debt | $m | [348](/filings/0001056288-23-000029.md) | [348](/filings/0001056288-25-000004.md) | [348](/filings/0001056288-24-000014.md) | [348](/filings/0001056288-24-000018.md) | [348](/filings/0001056288-24-000025.md) | [348](/filings/0001056288-26-000007.md) | [348](/filings/0001056288-25-000016.md) | [348](/filings/0001056288-25-000021.md) | [348](/filings/0001056288-25-000030.md) | [348](/filings/0001056288-26-000026.md) | [348](/filings/0001056288-26-000018.md) | [348](/filings/0001056288-26-000026.md) |
| Shareholders' equity | $m | [1,100](/filings/0001056288-24-000025.md) | [1,128](/filings/0001056288-26-000007.md) | [1,147](/filings/0001056288-25-000030.md) | [1,017](/filings/0001056288-25-000030.md) | [1,084](/filings/0001056288-25-000030.md) | [1,095](/filings/0001056288-26-000026.md) | [1,076](/filings/0001056288-26-000026.md) | [1,114](/filings/0001056288-26-000026.md) | [1,187](/filings/0001056288-25-000030.md) | [1,197](/filings/0001056288-26-000026.md) | [1,204](/filings/0001056288-26-000026.md) | [1,253](/filings/0001056288-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [106 d](/filings/0001056288-24-000025.md) | [130 d](/filings/0001056288-26-000007.md) | [14.0](/filings/0001056288-25-000016.md) | [88.7 d](/filings/0001056288-25-000021.md) | [117 d](/filings/0001056288-25-000030.md) | [127 d](/filings/0001056288-26-000007.md) | [14.3](/filings/0001056288-26-000018.md) | [18.8 d](/filings/0001056288-26-000026.md) | [103 d](/filings/0001056288-25-000030.md) | [161 d](/filings/0001056288-26-000007.md) | [28.8](/filings/0001056288-26-000018.md) | [80.9 d](/filings/0001056288-26-000026.md) |
| Capital expenditure | $m | [2.1 d](/filings/0001056288-24-000025.md) | [2.1 d](/filings/0001056288-26-000007.md) | [0.6](/filings/0001056288-25-000016.md) | [6.0 d](/filings/0001056288-25-000021.md) | [(3.0) d](/filings/0001056288-25-000030.md) | [0.5 d](/filings/0001056288-26-000007.md) | [1.0](/filings/0001056288-26-000018.md) | [0.8 d](/filings/0001056288-26-000026.md) | [1.4 d](/filings/0001056288-25-000030.md) | [(0.4) d](/filings/0001056288-26-000007.md) | [4.8](/filings/0001056288-26-000018.md) | [1.2 d](/filings/0001056288-26-000026.md) |
| Dividends paid | $m | [24.7 d](/filings/0001056288-24-000025.md) | [24.1 d](/filings/0001056288-24-000006.md) | [23.7](/filings/0001056288-24-000014.md) | [110 d](/filings/0001056288-24-000018.md) | [25.6 d](/filings/0001056288-24-000025.md) | [25.2 d](/filings/0001056288-26-000007.md) | [25.3](/filings/0001056288-26-000018.md) | [26.8 d](/filings/0001056288-26-000026.md) | [26.4 d](/filings/0001056288-25-000030.md) | [26.4 d](/filings/0001056288-26-000007.md) | [25.9](/filings/0001056288-26-000018.md) | [28.8 d](/filings/0001056288-26-000026.md) |
| Share repurchases | $m | [64.1 d](/filings/0001056288-24-000025.md) | [65.1 d](/filings/0001056288-26-000007.md) | [39.0](/filings/0001056288-25-000016.md) | [46.2 d](/filings/0001056288-25-000021.md) | [28.9 d](/filings/0001056288-25-000030.md) | [23.4 d](/filings/0001056288-26-000007.md) | [120](/filings/0001056288-26-000018.md) | [65.5 d](/filings/0001056288-26-000026.md) | [0.0 d](/filings/0001056288-25-000030.md) | [77.1 d](/filings/0001056288-26-000007.md) | [64.7](/filings/0001056288-26-000018.md) | [64.0 d](/filings/0001056288-26-000026.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [84.5](/filings/0001056288-23-000029.md) | [84.9](/filings/0001056288-24-000014.md) | [84.9](/filings/0001056288-24-000018.md) | [83.7](/filings/0001056288-24-000025.md) | [80.7](/filings/0001056288-25-000016.md) | [80.0](/filings/0001056288-25-000021.md) | [78.7](/filings/0001056288-25-000030.md) | [77.5](/filings/0001056288-26-000018.md) | [75.1](/filings/0001056288-26-000026.md) | [74.1](/filings/0001056288-25-000030.md) | [72.7](/filings/0001056288-26-000018.md) | [71.9](/filings/0001056288-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.